| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.072 | 0.2 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.2 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |